The Business Brew cover image

Thomas Ricketts, CFA - Investing in Innovation

The Business Brew

CHAPTER

Investing in Biotech Companies

I would say the first part of that was perhaps we got a bit extended last year. We had a tremendous number of companies that IPO or came via SPAC that in my opinion are pretty low quality businesses. And for those, it's like the baby's been thrown out with the bathwater. But I think biotech in particular still hasn't fully recovered. If you look at the larger pharma companies, they've now moved up in earnest. They're now a kind of five and 10 year kind of reversion to mean averages,. but quality biotech has a ways to go. E-commerce is very washed out. You can essentially buy the entire pipeline for free. Amazon is a good

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner